TransMedics Group Inc (TMDX)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 228,603 | 209,920 | 189,894 | 159,471 | 137,202 | 126,460 | 145,213 | 192,625 | 187,375 | 187,857 | 50,919 | 59,910 | 67,854 | 78,549 | 88,983 | 97,675 | 103,891 | 109,550 | 113,760 | 46,683 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $228,603K
= 0.00
TransMedics Group Inc has consistently maintained a debt-to-equity ratio of 0.00 throughout the mentioned periods from March 31, 2020, to December 31, 2024. A debt-to-equity ratio of 0.00 indicates that the company has no debt in relation to its equity, suggesting a conservative financial structure with a lower reliance on debt financing. This could be viewed positively by investors and creditors as it signifies a lower financial risk and potential for increased financial stability. However, it's important to note that a very low or zero debt-to-equity ratio could also indicate missed opportunities for leveraging debt for potential growth and expansion.
Peer comparison
Dec 31, 2024